查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1949508

血液分析儀及試劑市場－全球產業規模、佔有率、趨勢、機會及預測：產品及服務、終端用戶、應用、地區及競爭格局（2021-2031年）

Hematology Analyzers and Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product And Services, By End User, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血液分析儀和試劑市場預計將從 2025 年的 23.2 億美元成長到 2031 年的 35.1 億美元，複合年成長率為 7.14%。

血液分析儀作為自動化系統，可進行血球計數和形態學分析，而試劑則是實現這些診斷程序的關鍵化學溶液。推動該市場發展的主要因素是全球血液疾病（如白血病和貧血）盛行率的不斷上升，這導致對高通量、高精度檢測的持續需求。臨床檢查室為提高營運效率而大力推動高通量自動化，進一步加劇了這項需求。美國癌症協會估計，到2025年，美國將新增66,890例白血病病例，凸顯了診斷能力的迫切性。

市場概覽
預測期 2027-2031
市場規模：2025年 23.2億美元
市場規模：2031年 35.1億美元
複合年成長率：2026-2031年 7.14%
成長最快的細分市場 血紅素分析儀
最大的市場 北美洲

儘管市場呈現上升趨勢，但由於購買和維護先進的血液學檢測系統需要高昂的資本成本，因此仍面臨許多障礙。這項資金需求限制了技術的普及率，尤其是在預算有限的新興市場小規模獨立實驗室和醫療機構。此外，各地區複雜多元的法規環境也可能延緩創新診斷技術的核准和市場准入，減緩整個產業的擴張速度。

市場促進因素

人工智慧 (AI) 與數位影像技術的整合正在改變市場格局，顯著提升診斷準確性並最佳化檢查室工作流程。借助 AI 驅動的演算法，檢查室可以實現血球形態學檢測的自動化，減少對人工顯微鏡的依賴，降低人為誤差的風險。這項技術進步能夠加快檢測結果的交付速度，並提高檢測結果的一致性，使其成為高通量檢測中心不可或缺的一部分。 2025 年 7 月，Scopio Labs 的 AI 應用程式獲得 FDA 批准，該應用能夠分析紅血球形態和血小板凝集聚集情況，從而最佳化數位血液學檢測流程，這標誌著該領域取得了一項重大進展。

同時，隨著臨床檢查室尋求整合檢測流程，自動化和整合化血液學檢測工作站的日益普及正在推動市場成長。在人力有限的情況下，將細胞計數、玻片製備和染色整合於單一平台的高通量分析儀對於處理日益成長的檢體量至關重要。這種向自動化的轉變也反映在主要企業的財務表現中。例如，邁瑞醫療在2025年4月報告稱，由於市場對自動化解決方案的強勁需求，其體外診斷業務在2024年的銷售額成長了約11%。此外，英國國家醫療服務體系（NHS England）2025年8月的數據顯示，與前一年相比，2024年7月至2025年6月期間新增了超過160萬次診斷測試和掃描，這凸顯了高效基礎設施的迫切需求。

市場挑戰

安裝和維護先進的血液分析儀需要大量的資本投入，這構成了市場發展的一大阻礙因素。這些診斷系統需要大量的預付費用，這往往成為預算有限的小規模獨立實驗室和醫療機構採用這些系統的障礙。除了初始購置成本外，專用試劑、服務合約、操作人員培訓等持續累積的成本也會進一步加劇財務壓力。因此，許多機構被迫延長舊設備的使用壽命，而不是升級到更新、更有效率的自動化系統，減緩了維持市場成長所需的更新速度。

這種經濟壓力直接阻礙了下一代診斷技術的應用。據美國醫院協會 (AHA) 稱，到 2025 年，94% 的醫療機構管理者預計將因財務挑戰而推遲設備升級。這種不願投資資本資產的做法限制了新系統的部署數量，並抑制了製造商的收入成長。因此，由於採購決策經常被推遲以節省營運資金，市場在採用先進血液學解決方案方面正經歷放緩。

市場趨勢

照護現場（POC​​）血液檢測的日益普及正在重塑市場格局，它分散了診斷能力，並加快了重症監護環境下的檢測結果出爐速度。醫療機構正擴大部署採用微流體技術的緊湊型攜帶式分析儀，使他們能夠在患者床邊直接進行檢查室級的血液常規檢查（CBC）檢測，從而消除了與中心檢查室相關的物流延誤。這種轉變在急診室尤其重要，因為快速的臨床決策至關重要。例如，PixCell Medical公司於2025年6月發表的一項題為「利用HemoScreen CBC檢測改變智利急診護理」的案例研究表明，該公司的照護現場檢測分析儀可在10分鐘內提供檢測結果，平均比傳統檢查室檢測快20分鐘。

同時，新的臨床參數和生物標記的引入推動了對先進試劑和靈敏分析的需求。檢查室不再局限於標準的細胞計數，而是採用諸如未成熟血小板比例和網狀紅血球血紅蛋白等高級指標，從而更深入地了解膿毒症和貧血等病理狀況。這種對精細細胞分析的關注需要使用專業化的、高附加價值的專有試劑，從而直接提升了製造商的收入。希森美康公司（Sysmex Corporation）於2025年5月發布的《截至2025年3月的會計年度概要》也強調了這一趨勢，該報告顯示，亞太地區血液學檢測部門的銷售額同比成長17.6%。這一成長主要歸功於對診斷設備和試劑需求的不斷成長。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球血液分析儀及試劑市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品/服務分類（血液學、止血學、免疫血液學、血漿蛋白分析儀、血紅素分析儀、紅血球沉積速率分析儀、凝血分析儀、流式細胞儀、白血球分化分析儀）
    • 依最終使用者（醫院檢查室、血庫、研究/學術機構、其他）分類
    • 依應用領域（貧血、血癌、出血性疾病、感染疾病、免疫系統相關疾病等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美血液分析儀與試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲血液分析儀與試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區血液分析儀及試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東及非洲血液分析儀及試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美血液分析儀與試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球血液分析儀及試劑市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Sysmex Corporation
  • Danaher Corporation
  • Nihon Kohden Corporation
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Boule Diagnostics AB
  • Bio-Rad Laboratories Inc.
  • Biosystems SA
  • EKF Diagnostics Holdings Plc
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 22377

The Global Hematology Analyzers and Reagents Market is projected to expand from USD 2.32 Billion in 2025 to USD 3.51 Billion by 2031, registering a CAGR of 7.14%. Hematology analyzers act as automated systems for blood cell counting and morphology analysis, while reagents serve as the vital chemical solutions that enable these diagnostic procedures. The primary factor driving this market is the growing global prevalence of blood disorders, such as leukemia and anemia, which creates a sustained demand for high-volume, accurate testing. This need is further amplified by the push for high-throughput automation within clinical laboratories to enhance operational efficiency. Highlighting this urgency, the American Cancer Society estimates that 66,890 new cases of leukemia will be diagnosed in the United States in 2025, necessitating robust diagnostic capabilities.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.32 Billion
Market Size 2031USD 3.51 Billion
CAGR 2026-20317.14%
Fastest Growing SegmentHemoglobin Analyzers
Largest MarketNorth America

Despite this upward trajectory, the market encounters a substantial hurdle due to the high capital costs associated with purchasing and maintaining advanced hematology systems. This financial requirement restricts adoption rates, particularly among smaller independent laboratories and healthcare facilities in emerging markets that operate with limited budgets. Furthermore, complex and divergent regulatory environments across different regions can postpone the approval and market entry of innovative diagnostic technologies, thereby slowing the overall pace of industry expansion.

Market Driver

The incorporation of artificial intelligence and digital imaging technologies is transforming the market by significantly improving diagnostic accuracy and laboratory workflow. By utilizing AI-driven algorithms, laboratories can automate the morphological examination of blood cells, reducing the dependency on manual microscopy and mitigating the risk of human error. This technological evolution enables faster turnaround times and more consistent outcomes, which is essential for high-volume testing centers. A notable development in this sector was reported by Scopio Labs in July 2025, when the company obtained FDA clearance for an AI-powered application capable of analyzing red blood cell morphology and platelet clumps, thereby optimizing digital hematology processes.

Simultaneously, the rising adoption of automated and integrated hematology workstations is fueling market growth as clinical laboratories aim to consolidate their testing operations. High-throughput analyzers that integrate cell counting, slide preparation, and staining into a single platform are becoming indispensable for managing growing sample volumes amidst staffing constraints. This shift toward automation is reflected in the financial results of key industry players; for instance, Mindray reported in April 2025 that its In-Vitro Diagnostics revenue increased by nearly 11% in 2024, leading its divisions due to robust demand for automated solutions. Additionally, NHS England data from August 2025 indicated that over 1.6 million extra diagnostic tests and scans were conducted between July 2024 and June 2025 compared to the prior year, underscoring the vital need for efficient infrastructure.

Market Challenge

The substantial capital investment necessary to acquire and maintain sophisticated hematology analyzers acts as a major restraint on the market. These diagnostic systems require significant upfront expenditure, which is often prohibitive for smaller independent laboratories and healthcare facilities operating with constrained budgets. Beyond the initial purchase price, the ongoing cumulative costs of proprietary reagents, service agreements, and operator training place further stress on financial resources. Consequently, many institutions are compelled to extend the lifespan of older equipment rather than upgrading to newer, more efficient automation, thereby slowing the replacement rate required for market momentum.

This economic pressure directly hampers the adoption of next-generation diagnostic technologies. According to the American Hospital Association, in 2025, 94% of healthcare administrators anticipated delaying equipment upgrades to manage financial challenges. Such reluctance to invest in capital assets limits the number of new system installations and restricts revenue growth for manufacturers. As a result, the market experiences a slowdown in the proliferation of advanced hematology solutions, as purchasing decisions are frequently deferred to conserve operational capital.

Market Trends

The growing utilization of point-of-care (POC) hematology testing is reshaping the market by decentralizing diagnostic capabilities and accelerating results in critical care settings. Healthcare facilities are increasingly adopting compact, portable analyzers that employ microfluidic technology to perform lab-quality complete blood counts directly at the patient's bedside, thereby eliminating the logistical delays associated with central laboratories. This transition is particularly significant in emergency departments where rapid clinical decisions are crucial; for example, a case study by PixCell Medical in June 2025, titled 'Transforming Emergency Care in Chile with HemoScreen CBC Testing,' demonstrated that their point-of-care analyzer provided results in under 10 minutes, averaging 20 minutes faster than traditional laboratory testing.

In parallel, the introduction of novel clinical parameters and biomarkers is driving demand for advanced reagents and high-sensitivity analysis. Laboratories are moving beyond standard cell counts to incorporate advanced metrics such as immature platelet fraction and reticulocyte hemoglobin, which offer deeper insights into conditions like sepsis and anemia. This focus on detailed cellular profiling requires the consumption of specialized, high-value proprietary reagents, directly boosting manufacturer revenues. This trend is evident in Sysmex Corporation's May 2025 report, 'Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025,' which noted a 17.6% year-on-year increase in hematology segment sales within the Asia Pacific region, attributed largely to the rising demand for diagnostic instruments and reagents.

Key Market Players

  • Sysmex Corporation
  • Danaher Corporation
  • Nihon Kohden Corporation
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Boule Diagnostics AB
  • Bio-Rad Laboratories Inc.
  • Biosystems S.A.
  • EKF Diagnostics Holdings Plc
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Report Scope

In this report, the Global Hematology Analyzers and Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hematology Analyzers and Reagents Market, By Product And Services

  • Hematology
  • Hemostasis
  • Immunohematology
  • Plasma Protein Analyzer
  • Hemoglobin Analyzers
  • Erythrocyte Sedimentation Rate Analyzer
  • Coagulation Analyzer
  • Flow Cytometers
  • Differential Counters

Hematology Analyzers and Reagents Market, By End User

  • Hospital Laboratories
  • Blood Banks
  • Research and Academic Institute
  • Others

Hematology Analyzers and Reagents Market, By Application

  • Anemia
  • Blood Cancer
  • Hemorrhagic Conditions
  • Infection-Related Conditions
  • Immune-System Related Conditions
  • Others

Hematology Analyzers and Reagents Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hematology Analyzers and Reagents Market.

Available Customizations:

Global Hematology Analyzers and Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hematology Analyzers and Reagents Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product And Services (Hematology, Hemostasis, Immunohematology, Plasma Protein Analyzer, Hemoglobin Analyzers, Erythrocyte Sedimentation Rate Analyzer, Coagulation Analyzer, Flow Cytometers, Differential Counters)
    • 5.2.2. By End User (Hospital Laboratories, Blood Banks, Research and Academic Institute, Others)
    • 5.2.3. By Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection-Related Conditions, Immune-System Related Conditions, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Hematology Analyzers and Reagents Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product And Services
    • 6.2.2. By End User
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hematology Analyzers and Reagents Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product And Services
        • 6.3.1.2.2. By End User
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Hematology Analyzers and Reagents Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product And Services
        • 6.3.2.2.2. By End User
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Hematology Analyzers and Reagents Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product And Services
        • 6.3.3.2.2. By End User
        • 6.3.3.2.3. By Application

7. Europe Hematology Analyzers and Reagents Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product And Services
    • 7.2.2. By End User
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hematology Analyzers and Reagents Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product And Services
        • 7.3.1.2.2. By End User
        • 7.3.1.2.3. By Application
    • 7.3.2. France Hematology Analyzers and Reagents Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product And Services
        • 7.3.2.2.2. By End User
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Hematology Analyzers and Reagents Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product And Services
        • 7.3.3.2.2. By End User
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Hematology Analyzers and Reagents Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product And Services
        • 7.3.4.2.2. By End User
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Hematology Analyzers and Reagents Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product And Services
        • 7.3.5.2.2. By End User
        • 7.3.5.2.3. By Application

8. Asia Pacific Hematology Analyzers and Reagents Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product And Services
    • 8.2.2. By End User
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Hematology Analyzers and Reagents Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product And Services
        • 8.3.1.2.2. By End User
        • 8.3.1.2.3. By Application
    • 8.3.2. India Hematology Analyzers and Reagents Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product And Services
        • 8.3.2.2.2. By End User
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Hematology Analyzers and Reagents Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product And Services
        • 8.3.3.2.2. By End User
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Hematology Analyzers and Reagents Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product And Services
        • 8.3.4.2.2. By End User
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Hematology Analyzers and Reagents Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product And Services
        • 8.3.5.2.2. By End User
        • 8.3.5.2.3. By Application

9. Middle East & Africa Hematology Analyzers and Reagents Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product And Services
    • 9.2.2. By End User
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Hematology Analyzers and Reagents Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product And Services
        • 9.3.1.2.2. By End User
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Hematology Analyzers and Reagents Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product And Services
        • 9.3.2.2.2. By End User
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Hematology Analyzers and Reagents Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product And Services
        • 9.3.3.2.2. By End User
        • 9.3.3.2.3. By Application

10. South America Hematology Analyzers and Reagents Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product And Services
    • 10.2.2. By End User
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Hematology Analyzers and Reagents Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product And Services
        • 10.3.1.2.2. By End User
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Hematology Analyzers and Reagents Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product And Services
        • 10.3.2.2.2. By End User
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Hematology Analyzers and Reagents Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product And Services
        • 10.3.3.2.2. By End User
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Hematology Analyzers and Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Sysmex Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Danaher Corporation
  • 15.3. Nihon Kohden Corporation
  • 15.4. Siemens Healthineers AG
  • 15.5. Abbott Laboratories
  • 15.6. Boule Diagnostics AB
  • 15.7. Bio-Rad Laboratories Inc.
  • 15.8. Biosystems S.A.
  • 15.9. EKF Diagnostics Holdings Plc
  • 15.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer